Trial intelligence / Profile preview

Safety of Overestimation of Meal Insulin Bolus in Dual-hormone Closed-loop - Part 2

NCT02798250Phase 2Completed

Sponsor
Montreal Clinical Research Institute
Start
Jun 2016
Primary completion
Mar 2017
Countries
1
01

Overview

Phase 2, randomised, single-blind trial (2 arms), sponsored by Montreal Clinical Research Institute. Primary endpoint: Percentage of time below 4.0 mmol/L. Started Jun 2016; status: completed.

Beyond the preview

Go deeper on NCT02798250.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02798250.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call